Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)
Kuchenbauer, F; Bunjes, DW; Herr, W; Heuser, M; Spath, D; Casper, J; Horst, HA; Brossart, P; Held, G; Kobbe, G; Ringhoffer, M; Wattad, M; Salih, HR; Gotze, K; Wulf, G; Theobald, M; Rummel, MJ; Fiedler, W; Westermann, J; Salwender, H; Petzer, AL; Hartmann, F; Lubbert, M; Martens, U; Greil, R; Kirchner, HH; Paschka, P; Gaidzik, VI; Teleanu, V; Thol, F; Gohring, G; Dohner, K; Ganserxxx, A; Dohner, H; Schlenk, RF BLOOD. 2014; 124(21):
Clonal Evolution in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Melchardt, T; Hufnagl, C; Weigert, O; Weinstock, DM; Kopp, N; Weiss, L; Neureiter, D; Trankenschuh, W; Hackl, H; Greil, R; Egle, A BLOOD. 2014; 124(21):
Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstoker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R BLOOD. 2014; 124(21):
INCREASED CEREBRAL AMINO ACID UPTAKE DURING AND AFTER EPILEPTIC DISORDERS MIMICS BRAIN TUMOR IN F-18-FET PET
Hutterer, M; Krenn, Y; Kunz, A; McCoy, M; Egger, B; Schroder, M; Wendl, C; Marienhagen, J; Fritsch, B; Urbach, H; Meyer, PT; Galldiks, N; Langen, KJ; Hau, P; Trinka, E NEURO-ONCOLOGY. 2014; 16:
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
Keil, F; Selzer, E; Berghold, A; Reinisch, S; de Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsasser, W; Kainz, H; Riedl, R; Kapp, K; Kopp, M; Kornek, G ONCOL RES TREAT. 2014; 37: 273-273.
The integrin VLA-4 shows impaired CXCL12-induced inside-out activation in trisomy12 harboring chronic lymphocytic leukemia (CLL) cells
Ganghammer, S; Hutterer, E; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, PW; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, TN ONCOL RES TREAT. 2014; 37: 222-222.
Updated report of the Austrian CML registry
Schmidt, S; Sill, H; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Pober, M; Woell, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G ONCOL RES TREAT. 2014; 37: 57-58.
INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA
Ludwig, H; Weisel, K; Petrucci, MT; Leleu, X; Cafro, AM; Kropff, M; Greil, R; Zojer, N; Dummler, T; Kruschinski, A; Riecke, K; Foa, R; Yakoub-Agha, I; Engelhardt, M HAEMATOLOGICA. 2014; 99: 115-116.
AN INTERNATIONAL, MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF NEUTROPENIA IN PATIENTS BEING TREATED WITH LENALIDOMIDE plus DEXAMETHASONE FOR RELAPSED OR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RR-MM)
Leleu, X; Terpos, E; Sanz, RG; Cooney, J; OxxxGorman, P; Minarik, J; Greil, R; Williams, C; Gray, D; Szabo, Z HAEMATOLOGICA. 2014; 99: 368-368.
A PHASE II STUDY OF RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)
Raderer, M; Kiesewetter, B; Willenbacher, W; Neumeister, P; Fridrik, M; Greil, R HAEMATOLOGICA. 2014; 99: 226-226.